Side-Stepping Stock Direction Risk in Option Trading Before Earnings in Haemonetics Corporation – CML News

This Article Was Originally From This Site

Disclaimer
The results here are provided for general informational purposes, as a convenience to the readers. The materials are not a substitute for obtaining professional advice from a qualified person, firm or corporation.

Preface
For the investor that feel as though the market’s direction is becoming tenuous, we can explore an option trading opportunity in Haemonetics Corporation (NYSE:HAE) that does not rely on stock direction at all. It turns out, over the long-run, for stocks with certain tendencies like Haemonetics Corporation, there is a clever way to trade market anxiety or market optimism before earnings announcements with options.

This approach has returned 415.0% with a total holding period of just 78 days, or an annualized rate of 1,942.0%. Now that’s worth looking into.

This Article Was Originally From *This Site*